MonTa Biosciences
Simon is the CEO of MonTa Biosciences since establishment in 2015 and has led the company through several financing rounds and secured licensing on the companys current assets. Simon has a background as R&D manager in the biotech industry and is experienced in innovation, management, oncology, immunology, drug delivery, patenting and licensing.
MonTa Biosciences
MonTa Biosciences is a clinical stage biotech company located in the science park of The Danish Technical University in Kgs. Lyngby, North of Copenhagen. Their technology is a novel cancer immunotherapy approach using micelles to stimulate immune cells to migrate into tumor tissue leading to tumor cell killing within hours.